Article
Cancer driver genes and opportunities for precision oncology revealed by whole genome sequencing 10,478 cancers
2023-05-25
Abstract excerpt
<h4>ABSTRACT</h4> Identifying cancer driver genes is key for delivering the vision of precision oncology. The falling cost of whole genome sequencing (WGS) potentially makes WGS an attractive single all-encompassing test to identify cancer drivers in a patient, which may not be captured by standard panel testing but are targetable by small molecules. We analysed WGS data on 10,478 patients spanning 35 cancer types...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 26f2faec-55fa-5ca4-8126-5fb74b9e5333
- DOI
- 10.1101/2023.05.24.23289454
